Catalog No.
DHA30601
Expression system
Mammalian Cells
Species reactivity
Human
Host species
Humanized
Isotype
IgG4-kappa
Clonality
Monoclonal
Target
GDF-8, GDF8, MSTN, Myostatin, Growth/differentiation factor 8
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
O14793
Applications
Research Grade Biosimilar
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
LY-2495655, CAS: 1391726-30-9
Clone ID
Landogrozumab
LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial, PMID: 30051975
A Phase 2 Randomized Study Investigating the Efficacy and Safety of Myostatin Antibody LY2495655 versus Placebo in Patients Undergoing Elective Total Hip Arthroplasty, PMID: 26980371
Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial, PMID: 26516121
A Generic Detection Method for the Doping Control Analysis of Fc-Fusion Proteins and Monoclonal Antibodies in Equine Plasma., PMID:40033065
Simultaneous detection of myostatin-targeting monoclonal antibodies in dried blood spots and plasma using liquid chromatography-tandem mass spectrometry with field asymmetric ion mobility spectrometry., PMID:39405785
Understanding of sarcopenia: from definition to therapeutic strategies., PMID:34537916
LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial., PMID:30051975
A Phase 2 Randomized Study Investigating the Efficacy and Safety of Myostatin Antibody LY2495655 versus Placebo in Patients Undergoing Elective Total Hip Arthroplasty., PMID:26980371
Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial., PMID:26516121
For research use only. Not for human or drug use.
